Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040244
Filing Date
2025-03-17
Accepted
2025-03-17 16:09:38
Documents
138
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atai-20241231.htm   iXBRL 10-K 5923218
2 EX-4.2 atai-ex4_2.htm EX-4.2 246441
3 EX-10.3 atai-ex10_3.htm EX-10.3 109598
4 EX-10.4 atai-ex10_4.htm EX-10.4 222505
5 EX-10.28 atai-ex10_28.htm EX-10.28 138563
6 EX-19.1 atai-ex19_1.htm EX-19.1 82356
7 EX-21.1 atai-ex21_1.htm EX-21.1 13917
8 EX-23.1 atai-ex23_1.htm EX-23.1 4488
9 EX-31.1 atai-ex31_1.htm EX-31.1 15739
10 EX-31.2 atai-ex31_2.htm EX-31.2 16026
11 EX-32.1 atai-ex32_1.htm EX-32.1 9844
12 EX-32.2 atai-ex32_2.htm EX-32.2 9600
13 GRAPHIC img106891057_0.jpg GRAPHIC 38996
14 GRAPHIC img106891057_1.jpg GRAPHIC 131378
15 GRAPHIC img196761900_0.jpg GRAPHIC 11206
16 GRAPHIC img196761900_1.jpg GRAPHIC 11206
  Complete submission text file 0000950170-25-040244.txt   26157246

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atai-20241231.xsd EX-101.SCH 3498940
141 EXTRACTED XBRL INSTANCE DOCUMENT atai-20241231_htm.xml XML 4842616
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40493 | Film No.: 25744487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)